| Name |
Tn Antigen: Fmoc-Thr(GalNAc(Ac)₃-α-D)-OH
|
|---|
| Product No. | GA131000 |
|---|
| Synonym(s) |
Tn Epitope (Threonine); Tn Antigen (Threonine, Fmoc, Peracetylated); Fmoc-Thr(α-D-GalNAc(Ac)₃)-OH; Fmoc-Thr(alpha-D-GalNAc(Ac)₃)-OH; N-α-Fmoc-O-β-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-threonine; N-(9-fluorenylmethoxycarbonyl)-O-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-α-D-galactopyranosyl)-L-threonine
|
|---|
| Category | Glycoamino AcidsThreonine |
|---|
| CAS No. | 116783-35-8 |
|---|
| Formula | C33H38N2O13 |
|---|
| Molecular Weight | 670.66 |
|---|
| Availability | Yes |
|---|
| Availability in Bulk | Yes |
|---|
| Purity | >95% (HPLC) |
|---|
| Description | Tumor-Associated Carbohydrate Antigen (TACA). Tn is a truncated O-glycosylated core determinant with structure: GalNAcα-O-Ser/Thr. In normal Mamalian cells, the Tn determinant is masked by larger glycan residues. Once unmasked, Tn serves as an important recognition element, mediating several cell-cell interactions. As such, Tn is implicated in tumour cell organotropic metastasis. Targeting immune responses to truncated variants of O-glycan chains expressed by tumour cells represents a promising approach for the development of antigen-specific therapeutic vaccines against cancers, and accumulated evidence has rendered Tn a prime target for cancer immunotherapy. |
|---|
| Comments | N-Acetyl-D-Galactosamine; O-Link; Monosaccharide; Threonine; Blocked; Amino Acid; Ac |
|---|
| References | T. Ju, V.I. Otto and R.D. Cummings Angew. Chem. Int. Ed. 2011, 50, 1770 – 1794 |
|---|
| Datasheet(s) | GA131000_COA.pdf (84.002 KB)
|
|---|
